The DNA double-strand break response is abnormal in myeloblasts from patients with therapy-related acute myeloid leukemia
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The DNA double-strand break response is abnormal in myeloblasts from patients with therapy-related acute myeloid leukemia
Authors
Keywords
-
Journal
LEUKEMIA
Volume 28, Issue 6, Pages 1242-1251
Publisher
Springer Nature
Online
2013-12-05
DOI
10.1038/leu.2013.368
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- c-Myc Suppression of DNA Double-strand Break Repair
- (2015) Zhaozhong Li et al. NEOPLASIA
- Acquired copy number alterations of miRNA genes in acute myeloid leukemia are uncommon
- (2013) G. Ramsingh et al. BLOOD
- Mutational analysis of therapy-related myelodysplastic syndromes and acute myelogenous leukemia
- (2013) A. H. Shih et al. HAEMATOLOGICA
- The genomic landscape of hypodiploid acute lymphoblastic leukemia
- (2013) Linda Holmfeldt et al. NATURE GENETICS
- Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia
- (2013) NEW ENGLAND JOURNAL OF MEDICINE
- p53 promotes repair of heterochromatin DNA by regulating JMJD2b and SUV39H1 expression
- (2013) H Zheng et al. ONCOGENE
- Genome Sequencing of Pediatric Medulloblastoma Links Catastrophic DNA Rearrangements with TP53 Mutations
- (2012) Tobias Rausch et al. CELL
- TP53 alterations in acute myeloid leukemia with complex karyotype correlate with specific copy number alterations, monosomal karyotype, and dismal outcome
- (2011) F. G. Rucker et al. BLOOD
- Massive Genomic Rearrangement Acquired in a Single Catastrophic Event during Cancer Development
- (2011) Philip J. Stephens et al. CELL
- BET Bromodomain Inhibition as a Therapeutic Strategy to Target c-Myc
- (2011) Jake E. Delmore et al. CELL
- Identification of a Novel TP53 Cancer Susceptibility Mutation Through Whole-Genome Sequencing of a Patient With Therapy-Related AML
- (2011) Daniel C. Link JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia
- (2011) Johannes Zuber et al. NATURE
- The impact of therapy-related acute myeloid leukemia (AML) on outcome in 2853 adult patients with newly diagnosed AML
- (2010) S. Kayser et al. BLOOD
- Dephosphorylation of γ-H2AX by WIP1: An important homeostatic regulatory event in DNA repair and cell cycle control
- (2010) Sung-Hwan Moon et al. CELL CYCLE
- Gain of MYC underlies recurrent trisomy of the MYC chromosome in acute promyelocytic leukemia
- (2010) Letetia Jones et al. JOURNAL OF EXPERIMENTAL MEDICINE
- The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes
- (2009) J. W. Vardiman et al. BLOOD
- Acquired copy number alterations in adult acute myeloid leukemia genomes
- (2009) M. J. Walter et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Genetics of therapy-related myelodysplasia and acute myeloid leukemia
- (2008) J Pedersen-Bjergaard et al. LEUKEMIA
- Influence of DNA damage and repair upon the risk of treatment related leukemia
- (2008) Vicent Guillem et al. LEUKEMIA & LYMPHOMA
- Early events in the mammalian response to DNA double-strand breaks
- (2008) L. C. Riches et al. MUTAGENESIS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now